Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

被引：0

作者：

François-Clément Bidard

David Hajage

Thomas Bachelot

Suzette Delaloge

Etienne Brain

Mario Campone

Paul Cottu

Philippe Beuzeboc

Emilie Rolland

Claire Mathiot

Jean-Yves Pierga

机构：

[1] Institut Curie,Department of Medical Oncology

[2] Université Paris Descartes,Department of Biostatistics

[3] Institut Curie,Department of Medical Oncology

[4] Centre Léon Bérard,Department of Medical Oncology

[5] Institut Gustave Roussy,Department of Medical Oncology

[6] Institut Curie,Department of Medical Oncology

[7] Hôpital René Huguenin,Hematology laboratory

[8] Institut de Cancérologie de l'Ouest,undefined

[9] Bd Monod,undefined

[10] Institut Curie,undefined

来源：

Breast Cancer Research | / 14卷

关键词：

Progression Free Survival; Metastatic Breast Cancer; Circulate Tumor Cell; Serum Marker; Metastatic Breast Cancer Patient;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies [J].

Francisco J Esteva ;

Carol D Cheli ;

Herbert Fritsche ;

Monica Fornier ;

Dennis Slamon ;

Robert P Thiel ;

Diana Luftner ;

Farooq Ghani .

Breast Cancer Research, 7

[22] Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J].

Bahriye Aktas ;

Mitra Tewes ;

Tanja Fehm ;

Siegfried Hauch ;

Rainer Kimmig ;

Sabine Kasimir-Bauer .

Breast Cancer Research, 11

[23] Circulating tumor cells in metastatic inflammatory breast cancer [J].

Mego, M. ;

De Giorgi, U. ;

Hsu, L. ;

Ueno, N. T. ;

Valero, V. ;

Jackson, S. ;

Andreopoulou, E. ;

Kau, S. -W. ;

Reuben, J. M. ;

Cristofanilli, M. .

ANNALS OF ONCOLOGY, 2009, 20 (11) :1824-1828

[24] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer [J].

Imai, Hisao ;

Mori, Keita ;

Wakuda, Kazushige ;

Ono, Akira ;

Akamatsu, Hiroaki ;

Shukuya, Takehito ;

Taira, Tetsuhiko ;

Kenmotsu, Hirotsugu ;

Naito, Tateaki ;

Kaira, Kyoichi ;

Murakami, Haruyasu ;

Endo, Masahiro ;

Nakajima, Takashi ;

Yamamoto, Nobuyuki ;

Takahashi, Toshiaki .

ANNALS OF THORACIC MEDICINE, 2015, 10 (01) :61-66

[25] Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer [J].

Gill, S. ;

Berry, S. ;

Biagi, J. ;

Butts, C. ;

Buyse, M. ;

Chen, E. ;

Jonker, D. ;

Marginean, C. ;

Samson, B. ;

Stewart, J. ;

Thirlwell, M. ;

Wong, R. ;

Maroun, J. A. .

CURRENT ONCOLOGY, 2011, 18 :S5-S10

[26] Circulating tumor and endothelial cells as predictors of response in metastatic breast cancer [J].

M Cristofanilli .

Breast Cancer Research, 9

[27] The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer [J].

Wallwiener, Markus ;

Hartkopf, Andreas Daniel ;

Baccelli, Irene ;

Riethdorf, Sabine ;

Schott, Sarah ;

Pantel, Klaus ;

Marme, Frederik ;

Sohn, Christof ;

Trumpp, Andreas ;

Rack, Brigitte ;

Aktas, Bahriye ;

Solomayer, Erich-Franz ;

Mueller, Volkmar ;

Janni, Wolfgang ;

Schneeweiss, Andreas ;

Fehm, Tanja Natascha .

BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) :503-510

[28] A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival [J].

Beddowes, Emma J. ;

Duran, Mario Ortega ;

Karapanagiotis, Solon ;

Martin, Alistair ;

Gao, Meiling ;

Masina, Riccardo ;

Woitek, Ramona ;

Tanner, James ;

Tippin, Fleur ;

Kane, Justine ;

Lay, Jonathan ;

Brouwer, Anja ;

Sammut, Stephen-John ;

Chin, Suet-Feung ;

Gale, Davina ;

Tsui, Dana W. Y. ;

Dawson, Sarah-Jane ;

Rosenfeld, Nitzan ;

Callari, Maurizio ;

Rueda, Oscar M. ;

Caldas, Carlos .

MOLECULAR ONCOLOGY, 2025,

[29] Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients [J].

Vermaat, Joost S. ;

Gerritse, Frank L. ;

van der Veldt, Astrid A. ;

Roessingh, Wijnand M. ;

Niers, Tatjana M. ;

Oosting, Sjoukje F. ;

Sleijfer, Stefan ;

Roodhart, Jeanine M. ;

Beijnen, Jos H. ;

Schellens, Jan H. ;

Gietema, Jourik A. ;

Boven, Epie ;

Richel, Dick J. ;

Haanen, John B. ;

Voest, Emile E. .

EUROPEAN UROLOGY, 2012, 62 (04) :685-695

[30] The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer [J].

Markus Wallwiener ;

Andreas Daniel Hartkopf ;

Irène Baccelli ;

Sabine Riethdorf ;

Sarah Schott ;

Klaus Pantel ;

Frederik Marmé ;

Christof Sohn ;

Andreas Trumpp ;

Brigitte Rack ;

Bahriye Aktas ;

Erich-Franz Solomayer ;

Volkmar Müller ;

Wolfgang Janni ;

Andreas Schneeweiss ;

Tanja Natascha Fehm .

Breast Cancer Research and Treatment, 2013, 137 :503-510

← 1 2 3 4 5 →